Background—Although the relationship between mortality and time delay to treatment has
been demonstrated in patients with acute ST-segment elevation myocardial infarction …

The benefit of thrombolysis is dependent on time to treatment, but there is lack of evidence of
this relation in patients undergoing primary percutaneous transluminal coronary angioplasty …

Background In patients with acute myocardial infarction treated with thrombolysis, longer
times to treatment are associated with increasingly worse clinical outcome. This relation may …

Objectives. The purpose of this analysis was to determine the influence of an additional
treatment delay inherent in transfer to an angioplasty center for primary angioplasty of …

BACKGROUND: Previous reports have suggested an impact of patient's risk profile and
percutaneous coronary intervention (PCI)–related time delay on the benefits of primary …

In the treatment of acute myocardial infarction, delayed reperfusion therapy is associated
with increased mortality. Predictors of delay have been described for fibrinolysis but not for …

Objective: To determine the predictors of time between presentation and primary angioplasty
and the influence of this delay time on in-hospital mortality in clinical practice. Design …

The interval from the first alert of the healthcare system to the initiation of reperfusion therapy
(system delay) is associated with mortality in patients with ST-segment elevation myocardial …

BACKGROUND: The impact of treatment delays on outcomes after primary percutaneous
coronary intervention for acute myocardial infarction is controversial. METHODS: The …

Objectives: Our aim was to study the impact of delay from symptom onset to first coronary
device on infarct size and clinical outcomes at 30 days and 1 year in patients with ST …